NCT07364838已完成1 期
A Phase 1 Clinical Trial to Evaluate the Effect of Food on the Safety, Pharmacokinetics and Pharmacodynamics Characteristics of DW4421 in Healthy Adult Volunteers
干预措施
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 24
- 试验地点
- 1
- 主要终点
- Peak Plasma Concentration (Cmax)
研究概览
简要总结
A Randomized, Open-label, Oral in healthy volunteers
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy Volunteers who are ≥19 years old
- •Body weight ≥50.0 kg and BMI between 18.0 and 30.0 kg/m2
排除标准
- •Clinically significant Medical History
- •In the case of women, pregnant(Urine-HCG positive) or lactating women
研究组 & 干预措施
Sequence A
Experimental
Cross-over
干预措施: DW4421 (Drug)
Sequence B
Experimental
Cross-over
干预措施: DW4421 (Drug)
结局指标
主要结局
Peak Plasma Concentration (Cmax)
时间窗: up to 48 hours
Cmax of DW4421
Area under the plasma concentration versus time curve (AUC)
时间窗: up to 48 hours
AUC of DW4421
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Randomized, open-label clinical trial (Phase 1) to evaluate safety, tolerability, pharmacokinetics and food effects of a single dose of IM-250 in healthy volunteers2024-518155-37-00Innovative Molecules GmbH24
招募中
1 期
U69-CART-Cells For R/R T-ALLNCT07350863The First Affiliated Hospital of Soochow University12
尚未招募
不适用
GUARD-PH: Guided Use of AI-ECG for Risk Detection of PH in Surgery (GUARD-PH Trial)NCT07344207Taipei Veterans General Hospital, Taiwan1,380
尚未招募
1 期
A Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric CancerNCT07333573Shanghai Zhongshan Hospital42
进行中（未招募）
1 期
An open-label, phase I multicenter, clinical trial of NECVAX-NEO1 in addition to anti-PD-1 or anti-PD-L1 monoclonal antibody checkpoint inhibitor monotherapy in patients with solid tumors2024-513716-95-00Nec Oncoimmunity AS6